Skip to content
10-Q

Quarterly Report

OPTINOSE, INC.

0001494650-25-000072

← back to feed
Filed
May 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 1, 2025 10.13M sh
Shares Diluted Q1 2025 · Mar 31, 2025 11.67M sh
Shares Diluted restated Q1 2025 · Mar 31, 2024 7.53M sh
Capex Q1 2025 · Mar 31, 2025 $0
Capex Q1 2025 · Mar 31, 2024 $22K
Operating Cash Flow Q1 2025 · Mar 31, 2025 −$11.55M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$22.03M
Short Term Debt Q1 2025 · Mar 31, 2025 $127.21M
Short Term Debt Q1 2025 · Dec 31, 2024 $126.48M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $72.93M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $84.49M
Stockholders Equity Q1 2025 · Mar 31, 2025 −$61.37M
Stockholders Equity Q1 2025 · Dec 31, 2024 −$40.36M
Stockholders Equity Q1 2025 · Mar 31, 2024 −$99.22M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$86.61M
Current Liabilities Q1 2025 · Mar 31, 2025 $175.01M
Current Liabilities Q1 2025 · Dec 31, 2024 $162.81M
Total Liabilities Q1 2025 · Mar 31, 2025 $176.22M
Total Liabilities Q1 2025 · Dec 31, 2024 $169.15M
Current Assets Q1 2025 · Mar 31, 2025 $112.01M
Current Assets Q1 2025 · Dec 31, 2024 $125.84M
Total Assets Q1 2025 · Mar 31, 2025 $114.85M
Total Assets Q1 2025 · Dec 31, 2024 $128.79M
Eps Diluted Q1 2025 · Mar 31, 2025 −$1.92
Eps Diluted restated Q1 2025 · Mar 31, 2024 −$1.87
Eps Basic Q1 2025 · Mar 31, 2025 −$1.92
Eps Basic restated Q1 2025 · Mar 31, 2024 −$1.87
Sga Expense Q1 2025 · Mar 31, 2025 $23.59M
Sga Expense Q1 2025 · Mar 31, 2024 $20.52M
Rd Expense Q1 2025 · Mar 31, 2025 $760K
Rd Expense Q1 2025 · Mar 31, 2024 $1.21M
Net Income Q1 2025 · Mar 31, 2025 −$22.42M
Net Income Q1 2025 · Mar 31, 2024 −$14.07M
Operating Income Q1 2025 · Mar 31, 2025 −$7.59M
Operating Income Q1 2025 · Mar 31, 2024 −$8.08M
Cost Of Revenue Q1 2025 · Mar 31, 2025 $1.75M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $1.23M
Revenue Q1 2025 · Mar 31, 2025 $18.51M
Revenue Q1 2025 · Mar 31, 2024 $14.88M